Evidence map›Paper›PMID 11997524›Full record

ArticleMolecular and cellular biology2002

Characterization of a high-molecular-weight Notch complex in the nucleus of Notch(ic)-transformed RKE cells and in a human T-cell leukemia cell line.

Shawn Jeffries, David J Robbins, Anthony J Capobianco

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 143 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Positive autoregulation ofDevelopment (Cambridge, England) · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Notch Signaling in Neuroendocrine Tumors.Frontiers in oncology · 2016
    Review
  14. Article
  15. Article
  16. Article
  17. Wnt-Notch signalling crosstalk in development and disease.Cellular and molecular life sciences : CMLS · 2014
    Review
  18. Inhibition of CK2α down-regulates Notch1 signalling in lung cancer cells.Journal of cellular and molecular medicine · 2013
    Article
  19. Article
  20. VEGF and Notch in tip and stalk cell selection.Cold Spring Harbor perspectives in medicine · 2013
    Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shawn JeffriesDepartment of Molecular Genetics, Biochemistry and Microbiology, College of Medicine, University of Cincinnati, Cincinnati, Ohio 45267-0524, USA.
David J Robbins
Anthony J Capobianco
University of Cincinnati · US

Funding

MOLECULAR MECHANISMS OF NOTCH SIGNALING IN NEOPLASIAR01CA083736 · NCI · WISTAR INSTITUTE · PI CAPOBIANCO, ANTHONY JOHN · 2000 to 2016
$4.0M
NCI NIH HHS R01 CA083736NCI NIH HHS R01CA83736-02
6 · The paper itself

Abstract

Notch genes encode a family of transmembrane proteins that are involved in many cellular processes, such as differentiation, proliferation, and apoptosis. It is well established that all four Notch genes can act as oncogenes; however, the mechanism by which Notch proteins transform cells remains unknown. Previously, we reported that both nuclear localization and transcriptional activation are required for neoplastic transformation of RKE cells. Furthermore, we identified cyclin D1 as a direct transcriptional target of constitutively active Notch molecules. In an effort to understand the mechanism by which Notch functions in the nucleus, we sought to determine if Notch formed stable complexes using size exclusion chromatography. Herein, we report that the Notch intracellular domain (N(ic)) forms distinct high-molecular-weight complexes in the nuclei of transformed RKE cells. The largest complex is approximately 1.5 MDa and contains both endogenous CSL (for CBF1, Suppressor of Hairless, and Lag-1) and Mastermind-Like-1 (Maml). N(ic) molecules that do not have the high-affinity binding site for CSL (RAM) retain the ability to associate with CSL in a stable complex through interactions involving Maml. However, Maml does not directly bind to CSL. Furthermore, Maml can rescue Delta RAM transcriptional activity on a CSL-dependent promoter. These results indicate that deletion of the RAM domain does not equate to CSL-independent signaling. Moreover, in SUP-T1 cells, N(ic) exists exclusively in the largest N(ic)-containing complex. SUP-T1 cells are derived from a T-cell leukemia that harbors the t(7;9)(q34;q34.3) translocation and constitutively express N(ic). Taken together, our data indicate that complex formation is likely required for neoplastic transformation by Notch(ic).

Indexed as

DNA-Binding ProteinsNuclear ProteinsAnimalsCell LineCell Transformation, NeoplasticHeLa CellsHumansLeukemia, T-CellMacromolecular SubstancesMembrane ProteinsMolecular WeightProtein Structure, TertiaryRatsReceptors, NotchRepressor ProteinsSignal TransductionDNA-Binding ProteinsMacromolecular SubstancesMAML1 protein, humanMembrane ProteinsNuclear ProteinsReceptors, NotchRepressor ProteinsTrans-ActivatorsTranscription Factors

Identifiers

PMID11997524
PMCPMC133837
OpenAlexW2112327962

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.